Fentanyl Transdermal System 25 mcg/h
Sponsors
Mylan Pharmaceuticals Inc
Conditions
Healthy
Phase 1
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System With Askina Derm Overlay
CompletedNCT00647686
Start: 2006-06-30End: 2006-07-31Updated: 2024-04-23
Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
CompletedNCT00647842
Start: 2005-11-30End: 2006-02-28Updated: 2024-04-23